Bynocs and Dr. Shroff’s Charity Eye Hospital have launched an Advanced Amblyopia & Binocular Vision Clinic to address common vision disorders affecting children and adults.
New Delhi, India — Bynocs, a global leader in AI-powered digital therapeutics for binocular vision disorders, has partnered with Dr. Shroff’s Charity Eye Hospital, one of India’s most respected institutions, to inaugurate an Advanced Amblyopia & Binocular Vision Clinic.
The clinic was officially opened in a ceremony attended by key figures including Dr. Umang Mathur, Chief Executive Officer of Dr. Shroff’s Charity Eye Hospital; Dr. Suma Ganesh, Director of Pediatric Ophthalmology & Strabismus; Dr. Shailja Tibrewal, Senior Consultant in Pediatric Ophthalmology & Strabismus; Dr. Soveeta Rath, also a Senior Consultant in Pediatric Ophthalmology & Strabismus; Mr. Atanu Hati, General Manager of Bynocs; and Md. Oliullah Abdal, Director of Bynocs.
Amblyopia, commonly known as Lazy Eye, affects approximately 3-5% of the population, making it the leading cause of preventable vision loss in children. If left untreated, amblyopia can persist into adulthood, severely limiting functional vision and overall quality of life.
Intermittent squint, or intermittent strabismus, is another significant binocular vision disorder that can affect individuals across all age groups. Symptoms may include double vision, headaches, difficulty focusing, and unstable eye alignment. Without effective management, these conditions can significantly impair visual performance and quality of life.
The newly established clinic aims to combine clinical expertise with Bynocs’ advanced digital therapy programs specifically designed to treat amblyopia and intermittent squint. The therapy employs AI-driven, game-like exercises that are engaging, suitable for home use, and clinically validated.
During the launch, Dr. Umang Mathur expressed his enthusiasm for the new clinic, stating, “This clinic is a milestone for eye care. With the right blend of clinical expertise and digital therapeutics like Bynocs, we can effectively manage binocular vision issues across all age groups.”
Dr. Suma Ganesh highlighted the evolution of treatment options for amblyopia, noting, “The therapeutic landscape for amblyopia has evolved. Earlier, only children were treated, but today, even adults with lazy eye can benefit. Bynocs offers a new horizon of hope for these patients.”
Dr. Shailja Tibrewal emphasized the demand for practical solutions in modern healthcare, stating, “Patients today expect clinically effective and practical solutions. Bynocs achieves both—bringing accessible, AI-driven therapy that promotes compliance and measurable outcomes.”
Dr. Soveeta Rath pointed out the increasing prevalence of intermittent squint, saying, “With this clinic, we can provide patients with early diagnosis and treatment supported by the latest digital therapeutic advances.”
Mr. Atanu Hati remarked on Bynocs’ global reach, stating, “With over 1,500 clinics and more than 30,000 patients treated worldwide, Bynocs is proud to extend its reach through this collaboration with Dr. Shroff’s Charity Eye Hospital.”
Md. Oliullah Abdal expressed pride in the partnership, saying, “We are privileged to partner with Dr. Shroff’s Charity Eye Hospital in this endeavor. Our mission is to help patients suffering from amblyopia and intermittent squint while driving innovation and research in binocular vision therapy.”
Bynocs is recognized as a pioneer in binocular vision care, offering AI-based digital therapy programs for amblyopia and intermittent squint. The company has received numerous accolades, including Top Innovation Awards from the All India Ophthalmological Society, the American Society of Cataract and Refractive Surgery, and the American Academy of Optometry. With a presence in over 1,500 clinics across multiple continents and more than 30,000 patients successfully treated, Bynocs continues to redefine the therapeutic landscape of vision care.
For more information about Bynocs and its offerings, visit their website.
Source: Original article